SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 29.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 200.38m
  • Volume: 230,111
  • Market Cap: £18.54m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 29.00
52 Week Low 7.25
Volume 230,111
Shares Issued 200.38m
Market Cap £18.54m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69% below the market average69% below the market average69% below the market average69% below the market average69% below the market average
77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average77.36% below the sector average
Price Trend
81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average81.65% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Income Not Available
Growth
18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average18.01% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

SBTX Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
16:10 50,000 @ 9.10p
15:44 1,153 @ 9.00p
15:44 718 @ 9.00p
15:44 67 @ 9.00p
14:08 3,720 @ 9.17p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page